A new blood test that could help doctors identify whether a patient has Alzheimer’s disease was cleared by the FDA last week.

Fujirebio's Lumipulse® G pTau217/β-Amyloid 1-42 Plasma Ratio test has the potential to shorten the Alzheimer's disease ...

This article is part of “Innovations In: Alzheimer's Disease” an editorially independent special report that was produced with financial support from Eisai. The first hints that Gregory Nelson might ...

The FDA has cleared Elecsys pTau181, the first blood test for use in primary care to help rule out Alzheimer’s disease in ...

Simple blood test gets green light by FDA to improve early detection of Alzheimer’s disease - Millions of Americans are living with Alzheimer’s and hundreds of thousands are diagnosed each year ...

The U.S. Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other causes of cognitive decline, providing a broader understanding of when the ...

Scientists at CSIRO, Australia's national science agency, have identified simpler and less invasive methods to improve ...